Learn More
Medchemexpress LLC NSC 107512 | 22242-89-3 | 100.0% | 324.29 | C12H16N6O5 | 5 MG

Supplier: Medchemexpress LLC HY1416875MG
NSC 107512 is a sangivamycin-like small molecule inhibitor of cyclin-dependent kinase 9 (CDK9) developed for research use. It has been shown to inhibit tumor cell growth and induce apoptosis in preclinical studies, and is supplied as a solid with characterized purity and analytical data to support biochemical and cell-based assays.
- High purity: 99.97%.
- Targeted CDK9 inhibitory activity for biochemical and cell-based assays.
- Supplied as a white to off-white solid for ease of handling and storage.
- Available in small milligram quantities and ready-to-use DMSO solution formats.
- Molecular formula and molecular weight provided to support experimental planning.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.